Real-time PCR analyses and western blot revealed that FAM134B was decrease in all 8 hepatocellular carcinoma cell lines at both the protein and mRNA levels, compared with non-tumor tissue (Fig. 1D and E). This evidence concerns the gene RETREG1 and hepatocellular carcinoma.